Filing Details
- Accession Number:
- 0001213900-19-013229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-19 21:55:24
- Reporting Period:
- 2019-07-17
- Accepted Time:
- 2019-07-19 21:55:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1444307 | Oncosec Medical Inc | ONCS | Pharmaceutical Preparations (2834) | 980573252 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755469 | Alpha Holdings, Inc. | Gangnam-Gu Apgujeong-Ro 62-Gil 17-10 Seoul M5 06016 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-17 | 30,000 | $2.57 | 1,611,000 | No | 4 | P | Indirect | By Alpha Biolabs |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Alpha Biolabs |
Footnotes
- Alpha Biolabs is a wholly-owned subsidiary of Alpha Holdings, Inc.
Billionaire Hedge Funds
